Insider Buying: Global Medical REIT (NYSE:XRN) COO Acquires 1,490 Shares of Stock

Posted by on May 12th, 2026

Global Medical REIT Inc. (NYSE:XRN – Get Free Report) COO Danica Holley bought 1,490 shares of the stock in a transaction on Tuesday, May 12th. The shares were bought at an average cost of $33.99 per share, for a total transaction of $50,645.10. Following the purchase, the chief operating officer owned 1,590 shares in the company, valued at $54,044.10. This trade represents a 1,490.00% increase in their position. The purchase was disclosed in a legal filing with the SEC, which can be accessed through this link.

Global Medical REIT Price Performance

Shares of NYSE:XRN traded up $0.57 during trading on Tuesday, reaching $34.11. The company had a trading volume of 422,301 shares, compared to its average volume of 119,647. The firm’s fifty day moving average is $35.08 and its 200 day moving average is $34.42. The company has a debt-to-equity ratio of 1.62, a quick ratio of 0.61 and a current ratio of 0.61. The firm has a market capitalization of $451.21 million, a PE ratio of -30.73 and a beta of 1.11. Global Medical REIT Inc. has a twelve month low of $29.05 and a twelve month high of $39.93.

Global Medical REIT Dividend Announcement

The company also recently announced a monthly dividend, which will be paid on Friday, September 18th. Shareholders of record on Thursday, August 20th will be given a $0.16 dividend. This represents a c) dividend on an annualized basis and a yield of 5.6%. The ex-dividend date is Thursday, August 20th. Global Medical REIT’s dividend payout ratio is -270.27%.

Wall Street Analyst Weigh In

A number of analysts have recently commented on the company. Compass Point reissued a “neutral” rating and issued a $38.00 price objective (down from $50.00) on shares of Global Medical REIT in a research note on Thursday, May 7th. Weiss Ratings cut Global Medical REIT from a “hold (c-)” rating to a “sell (d+)” rating in a research note on Monday. Finally, Wall Street Zen lowered Global Medical REIT from a “hold” rating to a “sell” rating in a report on Saturday. One equities research analyst has rated the stock with a Strong Buy rating, two have assigned a Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $39.67.

View Our Latest Report on XRN

Institutional Investors Weigh In On Global Medical REIT

Several large investors have recently modified their holdings of XRN. Invesco Ltd. raised its position in shares of Global Medical REIT by 30.5% during the second quarter. Invesco Ltd. now owns 1,518,668 shares of the company’s stock worth $10,524,000 after purchasing an additional 355,355 shares during the period. Alyeska Investment Group L.P. purchased a new stake in shares of Global Medical REIT during the third quarter valued at $9,997,000. Marshall Wace LLP lifted its holdings in shares of Global Medical REIT by 2,208.2% during the second quarter. Marshall Wace LLP now owns 291,708 shares of the company’s stock valued at $2,022,000 after purchasing an additional 279,070 shares during the last quarter. Heartland Advisors Inc. boosted its position in shares of Global Medical REIT by 177.4% in the 4th quarter. Heartland Advisors Inc. now owns 423,460 shares of the company’s stock valued at $14,288,000 after purchasing an additional 270,786 shares during the period. Finally, Hotchkis & Wiley Capital Management LLC purchased a new position in Global Medical REIT in the 3rd quarter worth about $7,798,000. 57.52% of the stock is owned by institutional investors.

Global Medical REIT Company Profile

(Get Free Report)

Global Medical REIT (NYSE: GMRE) is a real estate investment trust focused on owning and managing healthcare-related properties across the United States. The company acquires, develops and leases a diversified portfolio of medical office buildings, outpatient facilities, long-term care centers and other specialized healthcare real estate. By concentrating on essential healthcare assets, Global Medical REIT seeks to generate stable, long-term rental income under triple-net and modified gross lease structures.

Since its incorporation in 2016 and initial public offering in 2017, the company has pursued an acquisitive growth strategy targeting markets with strong demographic trends and limited supply of modern medical facilities.

Featured Stories

Insider Buying and Selling by Quarter for Global Medical REIT (NYSE:XRN)

Receive News & Ratings for Global Medical REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Global Medical REIT and related companies with MarketBeat.com's FREE daily email newsletter.